Intraoperative Lidocaine May Reduce Breast Cancer Surgery-Associated Neuropathic Pain
Large studies examining the efficacy of intraoperative lidocaine infusions on breast cancer surgery-associated pain were found to be feasible.
Neuropathic Pain
Structured Medical Management Improves Trigeminal Neuralgia Outcomes
A structured medical management program was found to improve outcomes in patients with trigeminal neuralgia after 2 years.
Are Herbal Products Effective for Treating Neuropathic Pain?
According to the results of a recent review, there is “insufficient” evidence to conclude that either nutmeg or St John’s wort are effective in helping treat pain in neuropathic conditions.
Mirogabalin May Be Safe, Effective on Postherpetic Neuralgia
Mirogabalin was found to be safe, well tolerated, and effective at alleviating postherpetic neuralgia-associated pain.
Spinal Cord Stimulation Shows Long-Term Effectiveness for Refractory Neuropathic Pain
Patients with chronic refractory neuropathic pain who had a spinal cord stimulation device implanted were found to still experience pain relief 2 years later.
PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain
The painDETECT questionnaire, when used in secondary care, may not be adapted for the identification of the neuropathic components of orofacial pain and may underestimate the complexity of this condition.
Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy
The use of short-segment stimulation along the ulnar sensory nerves and across the elbow may provide reliable diagnostic confirmation of ulnar neuropathies.
Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk
To investigate the association between hormone therapy and carpal tunnel syndrome risk, researchers conducted a secondary analysis of the Women’s Health Initiative (WHI) hormone therapy trials.
Central Risk Factors May Contribute to Neuropathic-Like Knee Pain
Neuropathic-like knee pain may be driven by central risk factors that include depression, anxiety, and pain catastrophizing.
FDA Fast-Tracks Non-Opioid Treatment for Neuropathic Pain
The treatment is currently being evaluated in a Phase 2 study (ELEVATE) in patients with major depressive disorder who have had an inadequate response to standard antidepressant therapy.
Next post in Neuropathic Pain
